Hiroshige Mikamo

1.9k total citations
170 papers, 1.3k citations indexed

About

Hiroshige Mikamo is a scholar working on Epidemiology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, Hiroshige Mikamo has authored 170 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Epidemiology, 57 papers in Infectious Diseases and 29 papers in Clinical Biochemistry. Recurrent topics in Hiroshige Mikamo's work include Bacterial Identification and Susceptibility Testing (28 papers), Antibiotics Pharmacokinetics and Efficacy (24 papers) and Antibiotic Resistance in Bacteria (22 papers). Hiroshige Mikamo is often cited by papers focused on Bacterial Identification and Susceptibility Testing (28 papers), Antibiotics Pharmacokinetics and Efficacy (24 papers) and Antibiotic Resistance in Bacteria (22 papers). Hiroshige Mikamo collaborates with scholars based in Japan, United States and Australia. Hiroshige Mikamo's co-authors include Yuka Yamagishi, Teruhiko Tamaya, Mao Hagihara, Nobuhiro Asai, Hideo Kato, Hiroyuki Suematsu, Kyoko Kawazoe, Daisuke Sakanashi, Jun Hirai and Koji Izumi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Hiroshige Mikamo

157 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshige Mikamo Japan 20 585 391 211 210 167 170 1.3k
Isao Miyairi Japan 22 826 1.4× 346 0.9× 229 1.1× 263 1.3× 178 1.1× 150 1.6k
Patricia Pavèse France 24 644 1.1× 468 1.2× 209 1.0× 97 0.5× 95 0.6× 113 1.6k
Güner Söyletir Türkiye 19 489 0.8× 327 0.8× 170 0.8× 170 0.8× 416 2.5× 93 1.3k
Kazufumi Hiramatsu Japan 21 534 0.9× 611 1.6× 151 0.7× 94 0.4× 228 1.4× 121 1.5k
Francisco Javier Méndez Spain 21 589 1.0× 226 0.6× 193 0.9× 229 1.1× 239 1.4× 58 1.5k
Elizabeth Palavecino United States 22 472 0.8× 529 1.4× 169 0.8× 98 0.5× 210 1.3× 89 1.4k
Mao‐Wang Ho Taiwan 20 561 1.0× 788 2.0× 227 1.1× 89 0.4× 144 0.9× 95 1.4k
Cheng‐Mao Ho Taiwan 22 445 0.8× 412 1.1× 268 1.3× 83 0.4× 136 0.8× 43 1.2k
Nobuyuki Shimono Japan 21 736 1.3× 620 1.6× 107 0.5× 200 1.0× 380 2.3× 97 1.8k
H Grant Stiver Canada 23 599 1.0× 300 0.8× 181 0.9× 180 0.9× 98 0.6× 60 1.4k

Countries citing papers authored by Hiroshige Mikamo

Since Specialization
Citations

This map shows the geographic impact of Hiroshige Mikamo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshige Mikamo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshige Mikamo more than expected).

Fields of papers citing papers by Hiroshige Mikamo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshige Mikamo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshige Mikamo. The network helps show where Hiroshige Mikamo may publish in the future.

Co-authorship network of co-authors of Hiroshige Mikamo

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshige Mikamo. A scholar is included among the top collaborators of Hiroshige Mikamo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshige Mikamo. Hiroshige Mikamo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kato, Hideo, et al.. (2025). A systematic review and meta-analysis on the efficacy of carbapenems versus metronidazole combination therapy in patients infected with Bacteroides spp.. Journal of Infection and Chemotherapy. 31(5). 102687–102687. 1 indexed citations
2.
Kato, Hideo, Takumi Umemura, Mao Hagihara, et al.. (2024). Development of a therapeutic drug‐monitoring algorithm for outpatients receiving voriconazole: A multicentre retrospective study. British Journal of Clinical Pharmacology. 90(5). 1222–1230. 4 indexed citations
3.
Asai, Nobuhiro, Wataru Ohashi, Yuichi Shibata, et al.. (2024). A 15-Year Observational Cohort of Acute Empyema at a Single-Center in Japan. Antibiotics. 13(12). 1205–1205. 1 indexed citations
4.
5.
Kato, Hideo, Mao Hagihara, Nobuhiro Asai, et al.. (2023). A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections. Mycoses. 66(9). 815–824. 13 indexed citations
6.
7.
Shibata, Yuichi, Mao Hagihara, Nobuhiro Asai, et al.. (2023). A Retrospective Study to Compare the Incidence of Hyponatremia after Administration between Linezolid and Tedizolid. Antibiotics. 12(2). 345–345. 1 indexed citations
8.
Asai, Nobuhiro, Yuichi Shibata, Jun Hirai, et al.. (2023). A Gap of Patients with Infective Endocarditis between Clinical Trials and the Real World. Journal of Clinical Medicine. 12(4). 1566–1566. 4 indexed citations
9.
Hirai, Jun, Daisuke Sakanashi, Yuji Kuge, et al.. (2022). Lemierre Syndrome Due to Dialister pneumosintes: A Case Report. Infection and Drug Resistance. Volume 15. 2763–2771. 6 indexed citations
10.
Asai, Nobuhiro, Wataru Ohashi, Takaaki Kishino, et al.. (2021). The combined score of quick SOFA and the charlson comorbidity index could be a poor prognostic indicator for in-hospital mortality among patients with necrotizing fasciitis. Journal of Infection and Chemotherapy. 27(6). 919–923. 3 indexed citations
11.
Kato, Hideo, Suzanne L. Parker, Jason A. Roberts, et al.. (2021). Population Pharmacokinetics Analysis of Amikacin Initial Dosing Regimen in Elderly Patients. Antibiotics. 10(2). 100–100. 5 indexed citations
12.
Asai, Nobuhiro, Daisuke Sakanashi, Hiroyuki Suematsu, et al.. (2019). Infective endocarditis caused by Cardiobacterium hominis endocarditis: A case report and review of the literature. Journal of Infection and Chemotherapy. 25(8). 626–629. 5 indexed citations
13.
Asai, Nobuhiro, Hiroyuki Suematsu, Atsuko Yamada, et al.. (2019). Brevibacterium paucivorans bacteremia: case report and review of the literature. BMC Infectious Diseases. 19(1). 344–344. 23 indexed citations
14.
Mori, Takeshi, Takumi Umemura, Mao Hagihara, & Hiroshige Mikamo. (2012). Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus. SHILAP Revista de lepidopterología.
15.
Ishihara, Satoshi, et al.. (2010). Phase III tazobactam/piperacillin (1:8) study in patients with sepsis or infective endocarditis. 58. 73–87. 1 indexed citations
16.
Mikamo, Hiroshige & Kyoichi Totsuka. (2005). [The comparison of optimized pharmacodynamic dosing strategy for meropenem using Monte Carlo simulation].. PubMed. 58(2). 159–67. 8 indexed citations
17.
Matsubara, Kousaku, et al.. (2000). EARLY ONSET NEONATAL SEPSIS CAUSED BY SEROTYPE VIII GROUP B STREPTOCOCCI. The Pediatric Infectious Disease Journal. 19(4). 359–360. 12 indexed citations
18.
Chong, Yunsop, et al.. (2000). Trends in serotypes and antimicrobial susceptibility of group B streptococci isolated in Korea. Journal of Infection and Chemotherapy. 6(2). 93–97. 22 indexed citations
19.
Mikamo, Hiroshige, et al.. (1999). Bacterial Isolates From Patients With Preterm Labor With and Without Preterm Rupture of the Fetal Membranes. Infectious Diseases in Obstetrics and Gynecology. 7(4). 190–194. 11 indexed citations
20.
Mikamo, Hiroshige, Kyoko Kawazoe, Yasumasa Sato, Atsushi Imai, & Teruhiko Tamaya. (1998). Preterm labor and bacterial intraamniotic infection: Arachidonic acid liberation by phospholipase A2 of Fusobacterium nucleatum. American Journal of Obstetrics and Gynecology. 179(6). 1579–1582. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isao Miyairi Breakdown of academic impact, for papers by Patricia Pavèse Breakdown of academic impact, for papers by Güner Söyletir Breakdown of academic impact, for papers by Kazufumi Hiramatsu Breakdown of academic impact, for papers by Francisco Javier Méndez Breakdown of academic impact, for papers by Elizabeth Palavecino Breakdown of academic impact, for papers by Mao‐Wang Ho Breakdown of academic impact, for papers by Cheng‐Mao Ho Breakdown of academic impact, for papers by Nobuyuki Shimono Breakdown of academic impact, for papers by H Grant Stiver
Rankless by CCL
2026